VERNIER JEAN-MICHEL has a total of 12 patent applications. Its first patent ever was published in 2007. It filed its patents most often in United States, Peru and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are SCHWINK LOTHAR, ORCHID CHEMICALS & PHARM LTD and KOLCZEWSKI SABINE.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 10 | |
#2 | Peru | 1 | |
#3 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Microorganisms | |
#5 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Vernier Jean-Michel | 12 |
#2 | Chen Huanming | 5 |
#3 | Bounaud Pierre-Yves | 4 |
#4 | Hopkins Stephanie | 4 |
#5 | O'Connor Patrick | 4 |
#6 | Matthews David | 3 |
#7 | Cheney Ian Wayne | 3 |
#8 | De La Rosa Martha Alicia | 3 |
#9 | Wu Jim Zhen | 3 |
#10 | Larson Gary Lee | 3 |
Publication | Filing date | Title |
---|---|---|
WO2014047330A1 | Novel raf kinase inhibitors | |
US2014221374A1 | Raf kinase inhibitors | |
US2013040983A1 | Raf kinase inhibitors | |
US2013012513A1 | Hedgehog inhibitors | |
US2011003850A1 | N-(4-(6-fluoro-3,4-dihydroisoquinolin-2(1H)-yl)-2,6-dimethylphenyl)-3,3-dimethylbutanamide as potassium channel modulators | |
US2009170885A1 | Naphthyridine derivatives as potassium channel modulators | |
US2008188561A1 | N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulators |